Lung Cancer Considered

By IASLCScience

Lung Cancer Considered episodes

September 06, 2022 Mesothelioma With Melina Marmarelis And Sanjay Popat
Treatment for malignant pleural mesothelioma has undergone dramatic shifts in the past few years. To discuss these changes and the research behind them, Lung Cancer Considered Host Dr. Stephen Liu welcomes Dr. Sanjay Popat and Dr. Melina Marmarelis. Dr. Popat is a Consultant Thoracic Medical Oncologist at The Royal Marsden and Professor of Thoracic Oncology at the Institute of Cancer Research, in London, England, and Chair of the British Thoracic Oncology Group. He is also on the Board of Directors for the Mesothelioma Applied Research Foundation. Dr. Marmarelis is an Assistant Professor of Medicine at the Hospital of the University of Pennsylvania and the Medical Director of the Penn Mesothelioma and Pleural Program.
31 min
August 16, 2022 Virtual Tumor Board PDL1 Negative NSCLC With Reyes Bernabé And Hoss Borghaei
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the management of metastatic, PDL1 negative NSCLC. He is joined by Dr. Hossein Borghaei and Dr. Reyes Bernabe Caro.
Dr. Borghaei is a professor and Chief of Thoracic Oncology at Fox Chase Cancer Center in Philadelphia. He was the lead author for CheckMate 057, was involved in many of the landmark immunotherapy trials, and is the national PI for the ongoing INSIGNA trial. Dr. Reyes Bernabe Caro is the Section Chief of Medical Oncology and Head of the Thoracic Tumor Unite at the Hospital Universitario Virgen Rocio in Seville, Spain. She also has extensive experience in immunotherapy combinations and is an author on the NADIM and CheckMate 227 studies.
37 min
August 12, 2022 Trastuzumab - Deruxtecan (T-DXd) With Lyudmila Bazhenova And Julien Mazieres
On the heels of accelerated approval by the US FDA, Dr. Stephen Liu discusses trastuzumab-deruxtecan (T-DXd) with medical oncologists and clinical investigators, Dr. Lyudmila Bazhenova, from the University of California, San Diego, and Dr. Julian Mazieres, from Toulouse University Hospital. T-DXd is an antibody-drug conjugate now approved for the treatment of HER2-mutant NSCLC, and in this episode, its design, efficacy, and safety are reviewed.
38 min
August 11, 2022 WCLC 2022 Wrap Up
It’s a wrap! Catch up on key highlights of the IASLC 2022 World Conference on Lung Cancer with Dr. Narjust Florez and Dr. Stephen Liu as they discuss the science, social engagement and notable abstracts with Dr. Ben Levy.
24 min
August 09, 2022 WCLC 2022 Daily Highlights - August 9
We’ve approached a remarkable close to the last day of the IASLC 2022 World Conference on Lung Cancer in Vienna, Austria. Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Florez interview Dr. Belinda King Kallimanis, Dr. Charles Rudin and Dr. Solange Peters about patient-centric clinical trial consent forms, an update on the Keynote 604 trial, the importance of women’s sexual health and new data on a combination of therapies for patients with KRAS mutations.
28 min
August 09, 2022 WCLC 2022 Daily Highlights (Spanish Version) - August 8
Destacados Diarios WCLC 2022 - 8 de Agosto
Es el tercer día de la Conferencia Mundial IASLC 2022 sobre Cáncer de Pulmón! La Dra. Narjust Florez recibe a dos investigadores fundamentales: El Dr. Mariano Provencio y La Dra. Enriqueta Felip, para discutir sus estudios mejor calificados.
13 min
August 08, 2022 WCLC 2022 Daily Highlights - August 8
It’s Day 3 at the IASLC 2022 World Conference on Lung Cancer! Dr. Narjust Florez hosts pivotal researchers Dr. Enriqueta Felip, Dr. Mariano Provencio, and Dr. Rachael Murray to discuss their top-rated studies. IASLC President Dr. Heather Wakelee also joins in to give insight on how the committee selected these high-ranked abstracts for this year’s Presidential Symposium.
41 min
August 07, 2022 WCLC 2022 Daily Highlights - August 7
In this special edition of Lung Cancer Considered recorded at the IASLC 2022 World Conference on Lung Cancer, hosts Dr. Narjust Florez and Dr. Stephen Liu interview researchers Dr. Chi-Fu Jeffrey Yang, Dr. Jarushka Naidoo and Mr. Koen de Nijs, PhD student, to discuss their recent findings from the significant studies presented today.
24 min
August 06, 2022 WCLC 2022 Preview with Meeting Chairs Robert Pirker and Silvia Novello
Today's podcast originates from the IASLC World Conference on Lung Cancer in Vienna. Hosts Dr. Stephen Liu and Dr. Narjust Florez interview IASLC WCLC 2022 Honorary Chair Dr. Robert Pirker and Chair Dr. Silvia Novello at the meeting. Dr. Pirker and Dr. Novello provide an overview of the meeting and give podcast listeners a glimpse of what to expect at the IASLC WCLC 2022.
17 min
August 02, 2022 IASLC Fellowship Grants With Grace Dy Fred Hirsch And Jarushka Naidoo
On this episode of Lung Cancer Considered, three past IASLC Fellowship Grants winners share their own stories of how these grants helped propel their careers. Hosted by Dr. Narjust Florez, guests include:
Dr. Grace Dy is an associate professor of medicine at Department of Medicine at Jacobs School of Medicine & Biomedical Sciences at the University of Buffalo and a medical thoracic oncologist at Roswell Park Cancer Center. Dr. Dy received an IASLC fellowship grant in 2007.
Fred R. Hirsch, MD, PhD, is Executive Director at the Center for Thoracic Oncology in The Tisch Cancer Institute at Mount Sinai (TCI) and the Joe Lowe and Louis Price Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. He is also Associate Director of Biomarker Discovery for TCI and a previous CEO of the IASLC. Dr. Hirsch received an IASLC fellowship grant in 2001.
Dr. Jarushka Naidoo is a medical oncologist at Beaumont Hospital in Dublin, Ireland, and an assistant professor at John Hopkins. She is a clinical/translational investigator, specializing in immunotherapy for lung cancer, and immune-related toxicity. Dr. Naidoo received an LCFA/BMS/ILCF Young Investigator Grant in 2020.
41 min

About Lung Cancer Considered

From the publisher's feed

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.